Equity

Company Background Home > Equity > Corporate Information > Company Background

Syncom Formulations (India) LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524470 NSE Symbol: SYNCOMF P/E (TTM) :51.11
ISIN Demat:INE312C01025 Div & Yield %:0 EPS (TTM) :0.27
Book Value (RS) :2.8693234 Market Cap (Rs Cr.):1297.2 Face Value (RS) :1
    Change Company 
Incorporation Year 1988
Registered Office 7 Niraj Indl Estate Andheri(E),Off Mahakali Caves Rd,
Mumbai,
Maharashtra-400093
Telephone 91-22-30887744
Fax 91-22-30887755
Chairman Kedarmal Bankda
Managing Director Vijay Shankarlal Bankda
Company Secretary Vaishali Agrawal
Auditor Sanjay Mehta & Associates
Face Value 1
Market Lot 1
Listing BSE,NSE
Registrar Ankit Consultancy Pvt Ltd
Plot No. 60,Electronic Complex,Pardeshipura,Indore - 452010

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)